ArticlePediatric blood & cancer2026

A High-Sensitivity Circulating Nucleic Acid Sequencing Assay for Assessing Treatment Response to Alectinib in a Pediatric Patient With ALK-Rearranged Non-Small Cell Lung Cancer.

Alberto D Guerra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.